by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Prognostic Significance of Neutrophil to Lymphocyte Ratio in Multiple Myeloma Patient Daniela DIACONESCU, Ana-Maria ILINESCU, Claudiu Dragos POPESCU, Dan Sebastian SOARE, Georgiana ENE, Horia BUMBEA Multiple myeloma represents a hematologic malignancy...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
A Retrospective Analysis of CLL Patients in a Romanian Hematology Center Ana-Maria IORDAN, Minodora Cezarina ONISAI, Anca RAITARU, Claudia DESPAN, Ionel GELATU, Silvia CIORTAN, Daniela GEORGESCU Background: Chronic lymphocytic leukemia (CLL) is the most common...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study Larisa ZIDARU, Sinziana BARBU, Ruxandra DRAGHICI, Sebastian Nicolae TIMOTEI, Daniel CORIU, Sorina Nicoleta...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU We report two cases of recurrent thrombotic thrombocytopenic purpura, both patients without...